Clene (CLNN) Notes Payables (2020 - 2025)
Clene (CLNN) posted Notes Payables of $2.4 million for Q4 2025, up 317.19% on a QoQ basis from $570000.0 in Q3 2025.
Analysis
Clene (CLNN) Notes Payables (2020 - 2025) Analysis & Trends
Clene has reported Notes Payables for 5 years, with the latest figure at $2.4 million in Q4 2025.
- On a quarterly basis, Notes Payables changed N/A year-over-year to $2.4 million in Q4 2025; TTM through Dec 2025 was $2.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at $2.4 million, changed N/A from the prior year.
- Notes Payables was $2.4 million for Q4 2025 at Clene, up from $570000.0 in the prior quarter.
- The five-year high for Notes Payables was $20.5 million in Q2 2024, with the low at $570000.0 in Q3 2025.
- Average Notes Payables over 4 years is $9.3 million, with a median of $9.7 million recorded in 2023.
- The sharpest annual moves came in 2023 and 2025: Notes Payables soared 127.91% in 2023, then slumped 94.76% in 2025.
- Over 4 years, Notes Payables stood at $6.4 million in 2022, then jumped by 127.91% to $14.6 million in 2023, then declined by 25.65% to $10.9 million in 2024, then tumbled by 78.13% to $2.4 million in 2025.
- The last three Notes Payables figures came in at $2.4 million (Q4 2025), $570000.0 (Q3 2025), and $3.1 million (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn |
| 10 | Clene | 45.69 Mn | 45.69 Mn | 54,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 2.38 Mn |
| Sep 30, 2025 | 570,000.00 |
| Mar 31, 2025 | 3.12 Mn |
| Sep 30, 2024 | 10.88 Mn |
| Jun 30, 2024 | 20.45 Mn |
| Mar 31, 2024 | 14.99 Mn |
| Dec 31, 2023 | 14.63 Mn |
| Sep 30, 2023 | 9.59 Mn |
| Mar 31, 2023 | 9.75 Mn |
| Dec 31, 2022 | 6.42 Mn |
| Dec 31, 2020 | 5.92 Mn |